Corvus Pharmaceuticals, Inc.盘中异动急速下跌5.26%报21.80美元

市场透视01-27

北京时间2026年01月27日22时50分，Corvus Pharmaceuticals, Inc.（CRVS.us）股票出现异动，股价快速下跌5.26%。截至发稿，该股报21.80美元/股，成交量21.4429万股，换手率0.26%，振幅7.21%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.16百万美元，每股收益-0.12美元，毛利-28000.00美元，市盈率-40.54...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2606732023?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-27 22:50","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2606732023","market":"us","top_or_hot":-1,"title":"Corvus Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报21.80美元","media":"市场透视","content":"<div>\n<p>北京时间2026年01月27日22时50分，Corvus Pharmaceuticals, Inc.（CRVS.us）股票出现异动，股价快速下跌5.26%。截至发稿，该股报21.80美元/股，成交量21.4429万股，换手率0.26%，振幅7.21%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.16百万美元，每股收益-0.12美元，毛利-28000.00美元，市盈率-40.54...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127225051953e981a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corvus Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报21.80美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorvus Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报21.80美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-27 22:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127225051953e981a&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2026年01月27日22时50分，Corvus Pharmaceuticals, Inc.（CRVS.us）股票出现异动，股价快速下跌5.26%。截至发稿，该股报21.80美元/股，成交量21.4429万股，换手率0.26%，振幅7.21%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.16百万美元，每股收益-0.12美元，毛利-28000.00美元，市盈率-40.54...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127225051953e981a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4568","symbol_name":"美国抗疫概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127225051953e981a&s=b","article_id":"2606732023","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127225051953e981a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2606732023","pubTimestamp":1769525450,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2026年01月27日22时50分，Corvus Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.26%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Biomx Inc.、阿诺医药、Acumen Pharmaceuticals, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为948.85%、692.84%、218.21%，振幅较大的相关个股有Biomx Inc.、Genenta Science Spa、Kazia Therapeutics Limited，振幅分别为53.90%、29.23%、21.94%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4568":"美国抗疫概念","BK4139":"生物科技","CRVS":"Corvus Pharmaceuticals, Inc."},"translate_title":"Corvus Pharmaceuticals, Inc. fell 5.26% to $21.80 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRVS":1.5},"content_text":"北京时间2026年01月27日22时50分，Corvus Pharmaceuticals, Inc.（CRVS.us）股票出现异动，股价快速下跌5.26%。截至发稿，该股报21.80美元/股，成交量21.4429万股，换手率0.26%，振幅7.21%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.16百万美元，每股收益-0.12美元，毛利-28000.00美元，市盈率-40.54倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Biomx Inc.、阿诺医药、Acumen Pharmaceuticals, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为948.85%、692.84%、218.21%，振幅较大的相关个股有Biomx Inc.、Genenta Science Spa、Kazia Therapeutics Limited，振幅分别为53.90%、29.23%、21.94%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。其候选产品 soquelitinib 被设计为特异性结合一种参与T细胞激活、T细胞受体信号传导以及T细胞分化和功能的蛋白质——白细胞介素2诱导的T细胞激酶（ITK）。其他产品包括Ciforadenant（CPI-444）和Mupadolimab（CPI-006）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2606732023","isCrawlerRequest":true}

Corvus Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报21.80美元

精彩评论

Corvus Pharmaceuticals, Inc.盘中异动急速下跌5.26%报21.80美元